GSK3B and Alzheimer disease: Specifically, Wnt-signaling inhibits GSK3β, which otherwise phosphorylates APP on Thr668 (Saeki et al., 2011; Acevedo et al., 2014), contributing to the elevated p-Thr668 APP levels that are observed in the human AD brain (Lee et al., 2003; Figure 1Bii).